fbpx

Perioperative Management of Bleeding and Coagulation Disorders

Updated : October 4, 2022





Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

 
 

aminocaproic acid 


Indicated for Prevention of the Perioperative Bleeding Related to Cardiac Surgery as Off-label
100 mg/kg intravenously over 20-30 minutes following induction earlier to incision
100 mg/kg intravenously over 20-30 minutes during the cardiopulmonary bypass surgery
100 mg/kg intravenously following heparin reversal



 

Media Gallary

References

Perioperative Management of Bleeding and Coagulation Disorders

Updated : October 4, 2022




aminocaproic acid 


Indicated for Prevention of the Perioperative Bleeding Related to Cardiac Surgery as Off-label
100 mg/kg intravenously over 20-30 minutes following induction earlier to incision
100 mg/kg intravenously over 20-30 minutes during the cardiopulmonary bypass surgery
100 mg/kg intravenously following heparin reversal